Patin, E. C., Dillon, M. T., Nenclares, P., Grove, L., Soliman, H., Leslie, I., Northcote, D., Bozhanova, G., Crespo-Rodriguez, E., Baldock, H., Whittock, H., Baker, G., Kyula, J., Guevara, J., Melcher, A. A., Harper, J., Ghadially, H., Smith, S., Pedersen, M., McLaughlin, M., & Harrington, K. J. (2022). harnessing radiotherapy-induced NK-cell activity by combining DNA damage–response inhibition and immune checkpoint blockade. Journal for immunotherapy of cancer, 10(3), . http://access.bl.uk/ark:/81055/vdc_100153009191.0x000010